Detalhe da pesquisa
1.
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
N Engl J Med
; 385(25): e90, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551224
2.
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
J Infect Dis
; 227(7): 907-916, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723871
3.
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022.
Clin Infect Dis
; 76(10): 1753-1760, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750643
4.
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
Clin Infect Dis
; 76(10): 1822-1831, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578137
5.
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Emerg Infect Dis
; 29(3): 599-604, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703252
6.
Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status - United States, October 10, 2022-January 8, 2023.
MMWR Morb Mortal Wkly Rep
; 72(4): 95-99, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701262
7.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
MMWR Morb Mortal Wkly Rep
; 72(7): 177-182, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795625
8.
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022.
MMWR Morb Mortal Wkly Rep
; 72(6): 145-152, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757865
9.
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States.
J Infect Dis
; 226(2): 342-351, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481950
10.
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Clin Infect Dis
; 75(Suppl 2): S147-S154, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856635
11.
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 109-117, 2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085226
12.
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
MMWR Morb Mortal Wkly Rep
; 71(39): 1235-1238, 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173757
13.
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
MMWR Morb Mortal Wkly Rep
; 71(18): 633-637, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511708
14.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep
; 71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355612
15.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(48): 1526-1530, 2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454688
16.
Upsurge of Conjugate Vaccine Serotype 4 Invasive Pneumococcal Disease Clusters Among Adults Experiencing Homelessness in California, Colorado, and New Mexico.
J Infect Dis
; 223(7): 1241-1249, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798216
17.
Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
Clin Infect Dis
; 73(4): 650-658, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507250
18.
Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
Clin Infect Dis
; 72(12): e948-e956, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150366
19.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1163-1166, 2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437519
20.
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(20): 753-758, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014909